Arite Beclometasone

Arite Beclometasone



Kotra Pharma


Kotra Pharma
Concise Prescribing Info
Beclometasone dipropionate
Dosage/Direction for Use
Adult Mild to moderate asthma 50-200 mcg bd. Severe asthma Up to 400 mcg bd. Max: 800 mcg daily. Childn ≥5 yr 50 mcg bd.
Special Precautions
Discontinue use if paradoxical bronchospasm occurs. Not for immediate relief of asthma attacks. Severe asthma; adrenal suppression; Cushing's syndrome, Cushingoid features, adrenal suppression, decreased bone mineral density, cataract, glaucoma, psychological or behavioural effects eg, psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression (particularly in childn); active or latent pulmonary TB. Regularly monitor height of childn during prolonged use. Transferring from systemic corticosteroids. Avoid abrupt discontinuation. High-dose & prolonged use. Pregnancy & lactation. Growth retardation in childn & adolescents.
Adverse Reactions
Mouth & throat candidiasis; hoarseness, pharyngitis; taste disturbances.
Drug Interactions
Disulfiram or metronidazole; strong CYP3A inhibitors eg, ritonavir, cobicistat.
MIMS Class
Antiasthmatic & COPD Preparations
ATC Classification
R03BA01 - beclometasone ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, glucocorticoids.
Arite Beclometasone MDI 100 mcg/actuation
200 actuation x 1's
Arite Beclometasone MDI 50 mcg/actuation
200 actuation x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in